Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH: Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis. J Breast Cancer 2011, 14: 308-313. 10.4048/jbc.2011.14.4.308
Article
PubMed Central
PubMed
Google Scholar
Bal A, Joshi K, Sharma SC, Das A, Verma A, Wig JD: Prognostic Significance of Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast. Int J Surg Pathol 2008, 16: 251-256. 10.1177/1066896908314784
Article
PubMed
Google Scholar
Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y: Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer 1988, 61: 989-996. 10.1002/1097-0142(19880301)61:5<989::AID-CNCR2820610522>3.0.CO;2-E
Article
CAS
PubMed
Google Scholar
Di Saverio S, Gutierrez J, Avisar E: A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat 2008, 111: 541-547. 10.1007/s10549-007-9809-z
Article
PubMed
Google Scholar
Barkley CR, Ligibel JA, Wong JS, Lipsitz S, Smith BL, Golshan M: Mucinous breast carcinoma: a large contemporary series. Am J Surg 2008, 196: 549-51. 10.1016/j.amjsurg.2008.06.013
Article
PubMed
Google Scholar
Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO: Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005, 18: 1295-1304. 10.1038/modpathol.3800445
Article
CAS
PubMed
Google Scholar
Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E, Yonezawa S: Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology 2003, 42: 26-36. 10.1046/j.1365-2559.2003.01530.x
Article
CAS
PubMed
Google Scholar
Mcintire MG, Soucy G, Vaughan TL, Shahsafaei A, Odze RD: MUC2 Is a Highly Specific Marker of Goblet Cell Metaplasia in the Distal Esophagus and Gastroesophageal Junction. Am J Surg Pathol 2011, 35: 1007-1013. 10.1097/PAS.0b013e318218940d
Article
PubMed
Google Scholar
Li A, Goto M, Horinouchi M, Tanaka S, Imai K, Kim YS, Sato E, Yonezawa S: Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia. Pathol Int 2011, 51: 853-860.
Article
Google Scholar
Chu PG, Chung L, Weiss LM, Lau SK: Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol 2011, 35: 1830-1836. 10.1097/PAS.0b013e3182299c25
Article
PubMed
Google Scholar
Hanski C, Hofmeier M, Schmitt-Gräff A, Riede E, Hanski ML, Borchard F, Sieber E, Niedobitek F, Foss HD, Stein H, Riecken EO: Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol 1997, 182: 385-391. 10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q
Article
CAS
PubMed
Google Scholar
Lau SK, Weiss LM, Chu PG: Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004, 122: 61-69. 10.1309/9R6673QEC06D86Y4
Article
PubMed
Google Scholar
Adsay NV, Merati K, Nassar H, Shia J, Sarkar F, Pierson CR, Cheng JD, Visscher DW, Hruban RH, Klimstra DS: Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003, 27: 571-578. 10.1097/00000478-200305000-00002
Article
PubMed
Google Scholar
De Lott LB, Morrison C, Suster S, Cohn DE, Frankel WL: CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med 2005, 129: 1100-1105.
PubMed
Google Scholar
Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y, Kurihara T, Ojima Y, Okajima M, Asahara T: Immunohistochemical and mutational analyses of beta-catenin, K-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Clin Cancer Res 2003, 9: 5660-5665.
CAS
PubMed
Google Scholar
Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E: Mucinous cancers have fewer genomic alterations than more common classes of breast cancer. Breast. Cancer Res Treat 2002, 76: 255-260. 10.1023/A:1020808020873
Article
CAS
Google Scholar
Lacroix-Triki M, Suarez PH, Mackay A, Lambros MB, Natrajan R, Savage K, Geyer FC, Weigelt B, Ashworth A, Reis-Filho JS: Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol 2010, 222: 282-298. 10.1002/path.2763
Article
CAS
PubMed
Google Scholar
Kato N, Endo Y, Tamura G, Katayama Y, Motoyama T: Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation. Pathol Int 1999, 49: 947-955. 10.1046/j.1440-1827.1999.00975.x
Article
CAS
PubMed
Google Scholar
Weigelt B, Geyer FC, Horlings HM, Kreike B, Halfwerk H, Reis-Filho JS: Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol 2009, 22: 1401-1414. 10.1038/modpathol.2009.112
Article
CAS
PubMed
Google Scholar
Scopsi L, Andreola S, Pilotti S, Bufalino R, Baldini MT, Testori A, Rilke F: Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol 1994, 18: 702-711. 10.1097/00000478-199407000-00006
Article
CAS
PubMed
Google Scholar
Sáez C, Japón MA, Poveda MA, Segura DI: Mucinous (colloid) adenocarcinomas secrete distinct O-acylated forms of sialomucins: a histochemical study of gastric, colorectal and breast adenocarcinomas. Histopathology 2001, 39: 554-560. 10.1046/j.1365-2559.2001.01286.x
Article
PubMed
Google Scholar
Liszka L, Zielinska-Pajak E, Pajak J, Gołka D: Colloid carcinoma of the pancreas: review of selected pathological and clinical aspects. Pathology 2008, 40: 655-563. 10.1080/00313020802436444
Article
CAS
PubMed
Google Scholar
Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, DE Bolos C, Cardesa A: Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 2005, 29: 806-813. 10.1097/01.pas.0000155856.84553.c9
Article
PubMed
Google Scholar
Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM: Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol 2005, 29: 359-367. 10.1097/01.pas.0000149708.12335.6a
Article
PubMed
Google Scholar
Pinto-De-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A: Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch 2002, 440: 304-310. 10.1007/s00428-001-0548-y
Article
CAS
PubMed
Google Scholar
Alameda F, Mejías-Luque R, Garrido M, De Bolós C: Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in normal and pathological endometrial tissues. Int J Gynecol Pathol 2007, 26: 61-65. 10.1097/01.pgp.0000225837.32719.c1
Article
PubMed
Google Scholar
Rossi G, Murer B, Cavazza A, Losi L, Natali P, Marchioni A, Migaldi M, Capitanio G, Brambilla E: Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol 2004, 28: 442-452. 10.1097/00000478-200404000-00003
Article
PubMed
Google Scholar
Hirabayashi K, Yasuda M, Kajiwara H, Itoh J, Miyazawa M, Hirasawa T, Muramatsu T, Murakami M, Mikami M, Osamura RY: Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression. Acta Histochem Cytochem 2008, 41: 15-21. 10.1267/ahc.08008
Article
PubMed Central
CAS
PubMed
Google Scholar
Geyer FC, Lacroix-Triki M, Savage K, Arnedos M, Lambros MB, Mackay A, Natrajan R, Reis-Filho JS: β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod Pathol 2011, 24: 209-231. 10.1038/modpathol.2010.205
Article
CAS
PubMed
Google Scholar
Zhang YG, Du J, Tian XX, Zhong YF, Fang WG: Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Chin Med J 2007, 120: 1597-1605.
CAS
PubMed
Google Scholar
Dolled-Filhart M, Mccabe A, Giltnane J, Cregger M, Camp RL, Rimm DL: Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 2006, 66: 5487-5494. 10.1158/0008-5472.CAN-06-0100
Article
CAS
PubMed
Google Scholar
Wong NA, Pignatelli M: Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 2002, 160: 389-401. 10.1016/S0002-9440(10)64856-0
Article
PubMed Central
CAS
PubMed
Google Scholar
Raspollini MR, Amunni G, Villanucci A, Baroni G, Taddei A, Taddei GL: Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. Appl Immunohistochem Mol Morphol 2004, 12: 127-131.
Article
PubMed
Google Scholar
O’Connell FP, Wang HH, Odze RD: Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005, 129: 338-347.
PubMed
Google Scholar